Projects per year
Personal profile
Biography
Peter Donnan is Professor of Epidemiology and Biostatistics in the Medical School Division of Population Health and Genomics within the Medical Research Institute, University of Dundee. He has 35 years’ experience in the design and analysis of Health Services and Population Research observational studies as well as randomised controlled trials of drugs (steroids in Bell’s Palsy, NEJM, 2007) as well as public health interventions (screening for breast cancer, The Lancet, 1990, Football Fans In Training, The Lancet, 2014) and informatics (eSMART, BMJ 2021 and DQIP, NEJM 2016).
He leads the Dundee Epidemiology and Biostatistics Unit (DEBU) and co-leads the Tayside Clinical Trials Unit (TCTU) which has UKCRC registration and successfully manages approximately 20 clinical trials. He has also carried out extensive population record-linkage research on drug safety, adherence and management of long term conditions using Tayside’s and Scotland’s unique prescribing population databases and is the author of over 250 publications (h-index 60, m-index 1.42), as well as an investigator on research projects to a total of over £35 million.
He has developed a number of prognostic algorithms, most notably predicting Coronary Heart Disease (CHD) in people with type 2 diabetes (Diabetes Care, 2006), and Chief Scientist Office funded algorithm to predict risk of emergency admissions in primary care (PEONY) with a view to developing cost-effective interventions for long term conditions (Archives Internal Medicine, 2008). An NIHR HTA-funded study has developed aids to clinical decision making with abnormal liver function tests in primary care. He is senior author of a study to predict outcomes for those admitted to hospital with Acute Pancreatitis using health informatics across Scotland.
He has supervised 25 PhD and MSc students and externally examined PhD theses across the UK. He has developed Master’s level modules in clinical trials and provides a record linkage analysis module for the Dundee MPH (15 students) as well as the Scottish-wide Precision Medicine and Pharmacological Innovation MSc (35 students).
In 2004, Prof. Donnan was invited to become a member of the New Drugs Committee of the Scottish Medicines Consortium which seeks to advise Area and Drug Therapeutics Committees across Scotland regarding the cost-effectiveness of new drugs and continues in this work with expertise in indirect comparisons, missing data and survival analysis in trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Peter Donnan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chronic Pain Identification Through Using Electronic Records (C-PICTURE) (Joint with University of St Andrews, University of Aberdeen and NHS Fife)
Colvin, L. (Investigator), Donnan, P. (Investigator) & Smith, B. (Investigator)
1/07/23 → 31/10/25
Project: Research
-
The iDiabetes Platform - Enhanced Phenotyping of Patients With Diabetes For Precision Diagnosis, Prognosis and Treatment (Joint with NHS Education for Scotland and University of Aberdeen)
Bell, S. (Investigator), Croudace, T. (Investigator), Cunningham, S. (Investigator), Dillon, J. (Investigator), Doney, A. (Investigator), Donnan, P. (Investigator), Farre, A. (Investigator), Lang, C. (Investigator), McCrimmon, R. (Investigator), Mordi, I. (Investigator), Palmer, C. (Investigator) & Pearson, E. (Investigator)
1/05/22 → 30/04/26
Project: Research
-
Early Cancer Detection Test (CDT) Lung Screening Programme
Donnan, P. (Investigator), Fardon, T. (Investigator), McCowan, C. (Investigator), Schembri, S. (Investigator), Sullivan, F. (Investigator) & Treweek, S. (Investigator)
1/06/12 → 30/09/25
Project: Research
-
COVID-19 In Care-Homes In Tayside And Fife (Joint with NHS Tayside, University of Edinburgh and University of Gllasgow)
Donnan, P. (Investigator), Fletcher, E. (Investigator), Marwick, C. (Investigator) & Parcell, B. (Investigator)
1/05/21 → 31/10/21
Project: Research
-
Characterisation of COVID-19 Outcomes in a High-Risk Cohort: Assessment of Background Levels of Autoantibodies as a Prognostic Marker for Severe COVID-19 Infection (ECLS 3 Year Analysis)
Donnan, P. (Investigator)
1/04/21 → 31/10/21
Project: Research
-
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Shrestha, A. (Lead / Corresponding author), Bashir, T., Achison, M., Adamson, S., Akpan, A., Aspray, T., Avenell, A., Band, M. M., Burton, L. A., Cvoro, V., Donnan, P. T., Duncan, G. W., George, J., Gordon, A. L., Gregson, C. L., Hapca, A., Hume, C., Jackson, T. A., Kerr, S. & Kilgour, A. & 16 others, , 2 Aug 2024, In: PLoS ONE. 19, 8, 14 p., e0307268.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK
Ciaccio, L. (Lead / Corresponding author), Donnan, P. T., Parcell, B. J. & Marwick, C. A., Apr 2024, In: BMJ Open. 14, 4, 8 p., e081930.Research output: Contribution to journal › Article › peer-review
Open AccessFile20 Downloads (Pure) -
Death from cancer: frequent unscheduled care
Mills, S. E. E. (Lead / Corresponding author), Buchanan, D., Donnan, P. T. & Smith, B. H., 1 May 2024, In: BMJ Supportive & Palliative Care. 14, e1, p. E470-E475 6 p., 003448.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)35 Downloads (Pure) -
The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment- study protocol for a cluster-randomised controlled study
Lin, Y. Y., Leith, D., Abbott, M., Barrett, R., Bell, S., Croudace, T., Cunningham, S. G., Dillon, J. F., Donnan, P. T., Farre, A., Hernández, R., Lang, C., McKenzie, S., Mordi, I. R., Morrow, S., Munro, H. C., Ryan, M., Wake, D. J., Wang, H. & Win, M. & 1 others, , 21 Mar 2024, medRxiv, 20 p.Research output: Working paper/Preprint › Preprint
Open Access -
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis
Guthrie, B. (Lead / Corresponding author), Rogers, G., Livingstone, S., Morales, D. R., Donnan, P., Davis, S., Youn, J. H., Hainsworth, R., Thompson, A. & Payne, K., Feb 2024, In: Health and Social Care Delivery Research. 12, 4, 308 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile38 Downloads (Pure)
Activities
- 1 Membership of group
-
Scottish Medicines Consortium (External organisation)
Donnan, P. (Member)
2014Activity: Membership types › Membership of group